Selank

Could a peptide derived from the body's own immune system offer solutions to anxiety? Selank, a synthetic heptapeptide based on tuftsin, is currently under examination for its potential to modulate stress response and immune system activity. Researchers have begun to unravel its complex interactions within our biology, signaling exciting avenues for future exploration.

II. What is this compound?

Selank is a synthetic analog of the naturally occurring peptide tuftsin, comprising a seven-amino-acid sequence. Originating from its immunomodulatory counterpart, Selank was designed to enhance the body's stress response while influencing immune functions. The molecular structure includes the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, enabling its intriguing pharmacological profile.

III. How it works

Research indicates that Selank may inhibit enkephalinase, an enzyme associated with the metabolism of endogenous opioid peptides, potentially enhancing the body’s natural analgesic mechanisms [1] PMID: 21833148 . Additionally, it has been observed to modulate the release of pro-inflammatory cytokines like IL-6 and TNF-alpha, further implicating its role in combating neuroinflammation [2] PMID: 21493795 .

Furthermore, Selank's interaction with the GABAergic system is believed to contribute to its anxiolytic effects, which have garnered significant interest in clinical studies [3] PMID: 21833148 . These mechanisms showcase its potential to address both anxiety and related neurological conditions while hinting at broader implications for mental health therapies.

• Enkephalinase inhibition modulating endogenous opioid peptides
  PMID 21833148PMID 21493795
• IL-6 and TNF-alpha cytokine modulation affecting neuroinflammation
  PMID 21493795
• GABAergic system interaction promoting anxiolytic effects
  PMID 21833148

IV. Research Findings

Clinical studies suggest that Selank offers anxiety reduction, especially among individuals experiencing generalized anxiety disorder [4] PMID: 21833148 . Preliminary evidence also points to its potential for immune modulation, laying a foundation for further research into its impact on stress-related immune responses [5] PMID: 21493795 . Additionally, there are indications from preclinical findings that Selank may enhance cognitive functioning, making it a compelling subject of ongoing research [6] PMID: 21833148 .

• anxiety-reduction clinical
  PMID 21833148PMID 21493795
• immune-modulation preclinical
  PMID 21493795
• cognitive-enhancement preclinical
  PMID 21833148

V. Dosage Context Explained

Research indicates that typical dosages for intranasal administration of Selank range from 0.15 to 0.3 mg per day in clinical studies targeting anxiety symptoms [7] PMID: 21493795 . This flexibility in dosing underscores the importance of tailored approaches in studies exploring its effects on mental health.

• Administration Routes

  intranasal

  Range

  0.15–0.3 mg/day

  clinical studies for generalized anxiety disorder

  PMID 21493795

VI. Side Effects: Research Context

Although Selank is generally well-tolerated, some side effects have been reported, including nasal irritation when used as a spray and transient drowsiness at higher doses. Mild sedation may also occur, but further investigation is warranted to fully understand its safety profile in various populations.

• nasal irritation (with spray)
• transient drowsiness
• mild sedation at higher doses

VII. Frequently Asked Questions